Variable Behavior of iPSCs Derived from CML Patients for Response to TKI and Hematopoietic Differentiation

Aurélie Bedel; Jean- Max Pasquet; Éric Lippert; Miguel Taillepierre; Valérie Lagarde; Sandrine Dabernat; Pierre Dubus; Lucie Charaf; François Beliveau; Hubert de Verneuil; Emmanuel Richard; François-Xavier Mahon; François Moreau-Gaudry

doi:10.1371/journal.pone.0071596

Loading metrics

Open Access

Peer-reviewed

Research Article

Variable Behavior of iPSCs Derived from CML Patients for Response to TKI and Hematopoietic Differentiation

Aurélie Bedel,

Affiliations Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France, Université Bordeaux Segalen, Bordeaux, France
⨯
Jean- Max Pasquet,

Affiliation Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France
⨯
Éric Lippert,

Affiliations Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France, Université Bordeaux Segalen, Bordeaux, France
⨯
Miguel Taillepierre,

Affiliation Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France
⨯
Valérie Lagarde,

Affiliation Université Bordeaux Segalen, Bordeaux, France
⨯
Sandrine Dabernat,

Affiliations Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France, Université Bordeaux Segalen, Bordeaux, France
⨯
Pierre Dubus,

Affiliations Université Bordeaux, EA 2406, Bordeaux, France, Université Bordeaux Segalen, Bordeaux, France
⨯
Lucie Charaf,

Affiliation Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France
⨯
François Beliveau,

Affiliation Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France
⨯
Hubert de Verneuil,

Affiliations Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France, Université Bordeaux Segalen, Bordeaux, France
⨯
Emmanuel Richard,

Affiliations Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France, Université Bordeaux Segalen, Bordeaux, France
⨯
François-Xavier Mahon ,

Contributed equally to this work with: François-Xavier Mahon, François Moreau-Gaudry

* E-mail: fgaudry@u-bordeaux2.fr (FMG); Francois-Xavier.Mahon@u-bordeaux2.fr (FXM)

Affiliations Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France, Université Bordeaux Segalen, Bordeaux, France
⨯
François Moreau-Gaudry

Contributed equally to this work with: François-Xavier Mahon, François Moreau-Gaudry

* E-mail: fgaudry@u-bordeaux2.fr (FMG); Francois-Xavier.Mahon@u-bordeaux2.fr (FXM)

Affiliations Inserm U1035, Biothérapies des maladies génétiques et cancers, Bordeaux, France, Université Bordeaux Segalen, Bordeaux, France
⨯

Variable Behavior of iPSCs Derived from CML Patients for Response to TKI and Hematopoietic Differentiation

Aurélie Bedel,
Jean- Max Pasquet,
Éric Lippert,
Miguel Taillepierre,
Valérie Lagarde,
Sandrine Dabernat,
Pierre Dubus,
Lucie Charaf,
François Beliveau,
Hubert de Verneuil

Published: August 23, 2013
https://doi.org/10.1371/journal.pone.0071596

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cloning
Is the Subject Area "Cloning" applicable to this article?

Thanks for your feedback.
Induced pluripotent stem cells
Is the Subject Area "Induced pluripotent stem cells" applicable to this article?

Thanks for your feedback.
Cell differentiation
Is the Subject Area "Cell differentiation" applicable to this article?

Thanks for your feedback.
Stem cell therapy
Is the Subject Area "Stem cell therapy" applicable to this article?

Thanks for your feedback.
Pluripotency
Is the Subject Area "Pluripotency" applicable to this article?

Thanks for your feedback.
Stem cells
Is the Subject Area "Stem cells" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.